To address this need, we aimed to conduct a systematic review and meta-analysis of the accuracy of both CK-18 antigens (M30 and M65) in identifying NASH, fibrotic NASH, and fibrosis stages among NAFLD adults. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.